SCHEMBL6209666

SCHEMBL6209666

COC(=O)Cc1[nH]ccc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
ALDH1A1 P00352 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
MAPT P10636 4/20 0.40
KDM4E B2RXH2 3/20 0.40
HSD17B10 Q99714 2/20 0.40
HSP90AB1 P08238 1/20 0.39
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
GAA P10253 2/20 0.37
GFER P55789 1/20 0.37
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
EGFR P00533 2/20 0.36
TSHR P16473 1/20 0.35
RPS6KB2 Q9UBS0 1/20 0.35
TP53 P04637 1/20 0.34
PDGFRB P09619 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11395579 0.84 KMT2A (0.48) KMT2AALDH1A1SMN1; SMN2KDM4EHSD17B10
SCHEMBL3174185 0.77 SMN1; SMN2 (0.40) KMT2ACYP4F2CYP4A11ALDH1A1SMN1; SMN2
SCHEMBL11386830 0.77 KDM4E (0.42) KMT2AALDH1A1SMN1; SMN2KDM4EHSD17B10
SCHEMBL3716068 0.73 TSHR (0.35) KMT2AALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL28357703 0.69 CYP4F2 (0.40) KMT2ACYP4F2CYP4A11ALDH1A1SMN1; SMN2
SCHEMBL3588654 0.69 KDM4E (0.43) CYP4F2CYP4A11ALDH1A1SMN1; SMN2MAPT
SCHEMBL11908468 0.68 NPSR1 (0.47) KMT2AEGFRTSHR
SCHEMBL4802900 0.68 TSHR (0.45) KMT2ACYP4F2CYP4A11ALDH1A1SMN1; SMN2
SCHEMBL21550134 0.68 ALDH1A1 (0.49) CYP4F2CYP4A11ALDH1A1SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL3588652 0.68 KDM4E (0.43) CYP4F2CYP4A11ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383769-A4 6-SUBSTITUTED PYRAZOLO 3,4-D]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-08-03 EP disclosed
EP-1383769-A2 6-SUBSTITUTED PYRAZOLO 3,4-D]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2004-01-28 EP disclosed
WO-2002067654-A2 6-SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-09-06 WO disclosed
EP-0906279-A1 NOVEL PYRROLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-04-07 EP disclosed
WO-1997046524-A1 NOVEL PYRROLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1997-12-11 WO disclosed
EP-0763015-A1 SYSTEMATIC MODULAR PRODUCTION OF AMINIMIDE- AND OXAZOLONE- BASED MOLECULES HAVING AT LEAST TWO STRUCTURAL DIVERSITY ELEMENTS ARQULE, INC. (US) 1997-03-19 EP disclosed
EP-0023938-A1 Preparation of pyrrole-2-acetates McNeilab, Inc. (US) 1981-02-18 EP disclosed
EP-0010553-A1 Process of reducing a loweralkyl 1-loweralkyl-pyrrole-2-glyoxylate to a loweralkyl 1-loweralkyl-pyrrole-2-acetate McNeilab, Inc. (US) 1980-05-14 EP disclosed